本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
Recombinant Human Otoraplin (CHO-expressed)
别 名 | |
Cas号 | |
M D L | |
分子式 | |
分子量 | |
产品参数 | |
性状 | Recombinant Human Otoraplin (CHO-expressed) 是由 OTOR 编码的蛋白质,与 CDRAP/MIA 编码蛋白同源,在软骨的发育和维持中可能具有一定的作用。
Synonyms rHuOTOR; Fibrocyte-derived protein; Melanoma inhibitory activity-like protein; OTOR; MIAL ; 重组人内耳纤维细胞源性蛋白 (CHO 表达) Species Human Source CHO Accession Q9NRC9 Gene ID 56914 Molecular Weight 14-15 kDa AA Sequence VHGIFMDRLA SKKLCADDEC VYTISLASAQ EDYNAPDCRF INVKKGQQIY VYSKLVKENG AGEFWAGSVY GDGQDEMGVV GYFPRNLVKE QRVYQEATKE VPTTDIDFFC E Appearance Lyophilized powder. Formulation Lyophilized after extensive dialysis against PBS. Endotoxin Level <0.2 EU/μg, determined by LAL method. Reconstitution Reconstitute the lyophilized recombinant Human Otoraplin (CHO-expressed) (rHuOTOR) to 100 µg/mL using ddH2O or diluted with PBS. Storage & Stability Lyophilized recombinant Human Otoraplin (CHO-expressed) (rHuOTOR) is stored at -20°C. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer. It is recommended to freeze aliquots at -20°C or -80°C for extended storage. Shipping Room temperature in continental US; may vary elsewhere. Background Human Otoraplin is a protein encoded by OTOR gene, is homologous to the protein encoded by CDRAP/MIA, and may acts in cartilage development and maintenance[1]. |
贮存 |
- Recombinant Human Macrophage Inflammatory Protein-1 beta/CCL4 (CHO-expressed)
- Recombinant Human MPIF/CCL23, 85a.a. (CHO-expressed)
- Recombinant Human NANOG-TAT
- Recombinant Human Nephroblastoma Overexpressed Gene Protein (CHO-expressed)
- Recombinant Human Otoraplin (CHO-expressed)
- Recombinant Human OX40/TNFRSF4, His (HEK293-expressed)
- Recombinant Human PD-1, Fc Chimera (CHO-expressed)
- Recombinant Human PD-1, His (HEK293-expressed)
- Recombinant Human PD-L1, Fc Chimera (CHO-expressed)